Keros Therapeutics, Inc. (KROS)

18.77 +0.34 (+1.84%) USD  |  NASDAQ  |  Jan 21, 11:24
More

Keros Therapeutics Proceeds from Stock Option Exercised (Annual)

Proceeds from Stock Option Exercised (Annual) Chart

View Proceeds from Stock Option Exercised (Annual) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Annual) Benchmarks

View Proceeds from Stock Option Exercised (Annual) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Insmed, Inc. Upgrade
Innoviva, Inc. Upgrade
CorMedix, Inc. Upgrade